ClassIndications
- Schizophrenia
- Acute psychotic states and delirium
- Schizoaffective disorder
- Delusional disorders
- Ballism
- Tourette syndrome (a drug of choice)
- Occasionally as adjunctive therapy in mental retardation and the chorea of huntington disease
- Intractable hiccups
- ADHD
- Severe nausea and vomiting
Administration/Absorption Dosage Distribution Mechanism
Excretion
- Plasma concentrations of haloperidol decanoate reach a peak at about 6 days after the injection, falling thereafter, with an approx. half-life of 3 weeks
- Liver metabolism
Side effects Interactions Contraindications
- Absolute
- Preexisting coma, acute stroke
- Severe intoxication with alcohol or other central depressant drugs
- Known allergy against haloperidol or other butyrophenones or other drug ingredients
- Known heart disease; when combined will tend towards cardiac arrest
- Special caution needed
|
|